Piera Pierotti

708 total citations
21 papers, 402 citations indexed

About

Piera Pierotti is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Piera Pierotti has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 10 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Piera Pierotti's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Piera Pierotti is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Piera Pierotti collaborates with scholars based in Italy, United States and Spain. Piera Pierotti's co-authors include Francesco Mazzotta, Sergio Lo Caputo, Daria Trabattoni, Mario Clerici, Giampiero Carosi, Eugenia Quirós-Roldán, Mara Biasin, Carmine Tinelli, Francesca Fasano and Francesca Vichi and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Piera Pierotti

21 papers receiving 391 citations

Peers

Piera Pierotti
Christina Grube Switzerland
Emily Souder United States
S Sabally Gambia
Ivana Massud United States
Alex Dusek United States
Christina Grube Switzerland
Piera Pierotti
Citations per year, relative to Piera Pierotti Piera Pierotti (= 1×) peers Christina Grube

Countries citing papers authored by Piera Pierotti

Since Specialization
Citations

This map shows the geographic impact of Piera Pierotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera Pierotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera Pierotti more than expected).

Fields of papers citing papers by Piera Pierotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera Pierotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera Pierotti. The network helps show where Piera Pierotti may publish in the future.

Co-authorship network of co-authors of Piera Pierotti

This figure shows the co-authorship network connecting the top 25 collaborators of Piera Pierotti. A scholar is included among the top collaborators of Piera Pierotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera Pierotti. Piera Pierotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fusco, Francesco Maria, et al.. (2017). Reasons for switching ART: Comparison of data collected in 2012–2013 and 2014–2015 in Florence, Italy. International Journal of STD & AIDS. 29(4). 392–395. 2 indexed citations
2.
Mastrolorenzo, Antonio, et al.. (2017). Pleomorphic cutaneous xanthomas disclosing homozygous familial hypercholesterolemia. 6(4). 59–65. 2 indexed citations
3.
Raffetti, Elena, Laura Albini, D Gotti, et al.. (2015). Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. BMC Public Health. 15(1). 235–235. 28 indexed citations
4.
Taffon, Stefania, D. Genovese, Maria Blasi, et al.. (2014). HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study. Infection. 42(4). 675–687. 15 indexed citations
5.
Biasin, Mara, Luca Piacentini, Sergio Lo Caputo, et al.. (2010). TLR Activation Pathways in HIV-1–Exposed Seronegative Individuals. The Journal of Immunology. 184(5). 2710–2717. 46 indexed citations
6.
Quirós-Roldán, Eugenia, Carlo Torti, Giuseppe Lapadula, et al.. (2007). Adherence And Plasma Drug Concentrations Are Predictors of Confirmed Virologic Response after 24-Week Salvage Highly Active Antiretroviral Therapy. AIDS Patient Care and STDs. 21(2). 92–99. 4 indexed citations
7.
Torti, Carlo, Giuseppe Lapadula, Pablo Barreiro, et al.. (2007). CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. Journal of Antimicrobial Chemotherapy. 59(6). 1141–1147. 5 indexed citations
8.
Torti, Carlo, Franco Maggiolo, Andrea Patroni, et al.. (2005). Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort. Journal of Antimicrobial Chemotherapy. 56(1). 190–195. 29 indexed citations
9.
Caputo, Sergio Lo, Francesca Fasano, Francesca Vichi, et al.. (2005). Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS. 19(7). 653–661. 34 indexed citations
10.
Torti, Carlo, Maria Cristina Uccelli, Eugenia Quirós-Roldán, et al.. (2005). Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors. Journal of Clinical Virology. 35(4). 414–419. 8 indexed citations
11.
Monno, Laura, Gaetano Brindicci, Sergio Lo Caputo, et al.. (2005). HIV‐1 subtypes and circulating recombinant forms (CRFs) from HIV‐infected patients residing in two regions of central and southern Italy. Journal of Medical Virology. 75(4). 483–490. 38 indexed citations
12.
Torti, Carlo, Eugenia Quirós-Roldán, Francesca Moretti, et al.. (2004). Lopinavir Plasma Levels in Salvage Regimes by a Population of Highly Active Antiretroviral Therapy-Treated HIV-1–Positive Patients. AIDS Patient Care and STDs. 18(11). 629–634. 8 indexed citations
13.
Trabattoni, Daria, Sergio Lo Caputo, Francesca Vichi, et al.. (2004). Human α Defensin in HIV-Exposed But Uninfected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(5). 455–463. 55 indexed citations
14.
Pierotti, Piera, et al.. (2004). Discrepancy in virological and biochemistry response of patients with chronic hepatitis HCV positive on treatment with PEG-IFN plus ribavirin.. PubMed. 17(2). 205–6. 1 indexed citations
15.
Mazzotta, Francesco, Sergio Lo Caputo, Carlo Torti, et al.. (2003). Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(3). 268–280. 43 indexed citations
16.
Torti, Carlo, Eugenia Quirós-Roldán, Wilco Keulen, et al.. (2003). Comparison between Rules‐Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients. The Journal of Infectious Diseases. 188(2). 194–201. 38 indexed citations
17.
Pierotti, Piera, et al.. (1995). [Role of slime in the pathogenesis of pulmonary infections].. PubMed. 61(3). 77–81. 1 indexed citations
18.
Natoli, Clara, F. Dianzani, F. Mazzotta, et al.. (1993). 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.. PubMed. 6(4). 370–5. 31 indexed citations
19.
Ficarra, G, et al.. (1993). Clinical aspects and microbiology of HIV-associated periodontal lesions.. PubMed. 42(6). 301–9. 9 indexed citations
20.
Pierotti, Piera, et al.. (1960). Hydatid disease of horses, in Italy.. 13. 67–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026